Founded
Email
Recent investment activity
KANDO id: 368018
Corporate information
Official name
Alexion Pharmaceuticals Incorporated
Registration country
Company type
Complement inhibition for cardiovascular and inflammatory diseases.Funding rounds
| Investor | Profile | Country | |
|---|---|---|---|
| |
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. |
Investment activity status
Active investor
Selected investments
Displaying 1 - 2 of 2| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
| |
Taligen Therapeutics Inc | Acquisition USD 111,000,000 | ||||
| |
Enobia Pharma Corp | Acquisition USD 1,100,000,000 (USD 1,100,000,000) |